Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07063173 · ClinicalTrials.gov registry record · NA
Bioavailability of Ration Items Containing Tart Cherry Extract
A NA study of Bioavailability, sponsored by United States Army Research Institute of Environmental Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07063173 is a NA study of Bioavailability that is actively recruiting participants, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 15 participants, below the 36-participant average among 8 other Bioavailability trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07063173, a NA study of Bioavailability, is actively recruiting participants, sponsored by United States Army Research Institute of Environmental Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine how consuming food items containing shelf-stored tart cherry impacts your body's ability to absorb and use the compounds within tart cherry.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo beverage
- DIETARY_SUPPLEMENT Fruit Bar
- DIETARY_SUPPLEMENT Powdered Drink
- DIETARY_SUPPLEMENT Commercially available 100% tart cherry juice
Study Locations (1)
Massachusetts
- USARIEM - Natick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-06-14 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07063173
The ClinicalTrials.gov registry entry for NCT07063173 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36-participant average among 8 other Bioavailability trials with a reported enrollment target (58% lower). The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bioavailability appearing as the primary indexed condition, and to 4 interventions - of which Placebo beverage is the first listed.
NCT07063173 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07063173 about?
NCT07063173 is a clinical study titled "Bioavailability of Ration Items Containing Tart Cherry Extract". To determine how consuming food items containing shelf-stored tart cherry impacts your body's ability to absorb and use the compounds within tart cherry.
What is the current status of trial NCT07063173?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-06-14. Estimated completion is 2025-12-31.
What conditions does trial NCT07063173 study?
This clinical trial studies the following conditions: Bioavailability.
What interventions are being tested in trial NCT07063173?
The interventions under investigation include: Placebo beverage (DIETARY_SUPPLEMENT), Fruit Bar (DIETARY_SUPPLEMENT), Powdered Drink (DIETARY_SUPPLEMENT), Commercially available 100% tart cherry juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07063173?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07063173 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bioavailability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bioavailability of EPA + DHA in a SMEDS Formulation
COMPLETED · NA
-
Curcumin and Retinal Study
RECRUITING · Phase 1
-
A Study of TEPEZZA Subcutaneous Administration in Healthy Adults
COMPLETED · Phase 1
-
A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects
COMPLETED · Phase 1
-
Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants
COMPLETED · Phase 1
-
Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.